Description
Journal of Clinical and Aesthetic Dermatology (JCAD) is a peer-reviewed publication that has already become an important addition to the field of dermatology. Under the expert editorial leadership of James Del Rosso, DO, and Philip Werschler, MD, JCAD provides dermatologists with up-to-date, evidence-based information that can be applied to their daily practices. JCAD offers its readers original research, practical discussion on the latest research, comprehensive reviews, didactic case reports, and provocative commentaries on contemporary topics relating to both clinical and aesthetic dermatology, written by key opinion leaders as well as practicing clinicians who are “in the trenches,” providing vital balance to the research-rich literature that is already available. JCAD is the official journal of the American Cutaneous Oncology Society and the American Acne and Rosacea Society. JCAD is indexed on PubMed Central, Scopus, EMBASE, and CINAHL Plus.
Hide
Show More...
Screenshots
JCAD FAQ
-
Is JCAD free?
Yes, JCAD is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is JCAD legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does JCAD cost?
JCAD is free.
-
What is JCAD revenue?
To get estimated revenue of JCAD app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Italy yet.
Ratings History
JCAD Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
JCAD Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
Aesthetic Medicine Magazine
Inspiring Best Practice
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Fitzpatrick's Color Atlas
Clinical Dermatology
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
ABC of Dermatology
Diagnose & Manage Skin Disease
|
Unlock
|
Unlock
|
0
|
|
4 months ago | |
Dermatology Patient Pathways
|
Unlock
|
Unlock
|
0
|
|
4 years ago | |
Skin Therapy Letter
|
Unlock
|
Unlock
|
0
|
|
2 weeks ago | |
Skin Therapy Letter - Family P
|
Unlock
|
Unlock
|
0
|
|
8 years ago | |
Dermatology & Venereology
Global Journal app
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
Indigo Dermatology
|
Unlock
|
Unlock
|
0
|
|
5 years ago | |
Skin Infections and Treatments
|
Unlock
|
Unlock
|
0
|
|
5 years ago | |
Pediatric Dermatology from AAP
American Academy Pediatrics
|
Unlock
|
Unlock
|
0
|
|
3 years ago |
JCAD Installs
Last 30 days
JCAD Revenue
Last 30 daysJCAD Revenue and Downloads
Gain valuable insights into JCAD performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Matrix Medical Communications
- Languages
- English
- Recent release
- 7.1.5 (7 months ago )
- Released on
- Apr 9, 2013 (11 years ago )
- Also available in
- India , United States , Pakistan , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , South Africa , Poland , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , Vietnam , United Arab Emirates , Denmark , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , China , Colombia , Czechia , Germany , Israel , Dominican Republic , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.